Two Sigma Investments
TRAW icon

Two Sigma Investments’s Traws Pharma TRAW Stock Holding History

Two Sigma Investments’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.2K Hold
19,244
– – ﹤0.01% 4486
2025
Q4 		$21.7K Sell
19,244
-2,774
-13% -$6.17K ﹤0.01% 3990
2025
Q3 		$40.7K Buy
22,018
+5,955
+37% +$9.71K ﹤0.01% 3555
2025
Q2 		$23.8K Buy
+16,063
New +$25.6K ﹤0.01% 3109
2024
Q2 		– Sell
-1,519
Closed -$38.4K – 3392
2024
Q1 		$38.4K Sell
1,519
-57
-4% -$1.1K ﹤0.01% 2894
2023
Q4 		$29.4K Sell
1,576
-3,412
-68% -$58K ﹤0.01% 3038
2023
Q3 		$88.7K Sell
4,988
-1,324
-21% -$30.2K ﹤0.01% 2757
2023
Q2 		$186K Buy
+6,312
New +$170K ﹤0.01% 2660
2022
Q2 		– Sell
-2,545
Closed -$117K – 3009
2022
Q1 		$117K Sell
2,545
-169
-6% -$7.83K ﹤0.01% 2415
2021
Q4 		$173K Buy
+2,714
New +$218K ﹤0.01% 3962
2014
Q3 		– Hold
0
– -$58K – 2101
2014
Q2 		– Hold
0
– – – 2082

Other funds holding TRAW

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $478M AUM 50.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments's TRAW Position: Q1 2026 in Review

Two Sigma Investments held its Traws Pharma (TRAW) position steady in Q1 2026 at 19,244 shares worth $35.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4486.

Two Sigma Investments first reported a position in TRAW in Q4 2021 and has held it in 10 quarters since. The position peaked at $186K in Q2 2023. 28 funds tracked by Wall St. Rank hold TRAW as of Q1 2026.

  • Two Sigma Investments held 19,244 shares of Traws Pharma worth $35.2K as of Q1 2026.
  • Two Sigma Investments left its Traws Pharma share count unchanged in Q1 2026.
  • Traws Pharma made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #4486 holding.
  • Two Sigma Investments first reported a position in Traws Pharma in Q4 2021 and has held it in 10 quarters since.
  • Two Sigma Investments's Traws Pharma position peaked at $186K in Q2 2023.
  • 28 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.